DSCT:TASEIsrael Discount Bank Limited Class A Analysis
Data as of 2026-03-13 - not real-time
ILA 3,445.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Israel Discount Bank is trading well below its discounted cash‑flow estimate, offering a sizable margin of safety for value‑oriented investors. The stock’s price sits near a strong technical support level and the 20‑day SMA sits comfortably above the 50‑day SMA, indicating an underlying bullish bias. RSI is in oversold territory, suggesting potential upside momentum, while the MACD remains bearish, warning of short‑term weakness. Volume is on an upward trend, reinforcing the credibility of recent price moves. The bank’s dividend yield is attractive and the payout ratio is modest, supporting dividend sustainability. Fundamentals show a PE ratio that is comfortably below the industry average, and operating margins remain solid. Despite a very high price‑to‑book multiple, the balance sheet is strong with ample cash and a manageable debt profile. The market’s sentiment index leans toward greed, reflecting optimism in the broader environment. Combined, these factors point to a stock that is undervalued on a cash‑flow basis, offers a reliable income stream, and has technical signs of a possible rebound.
Investors should monitor the support zone for any breach, watch for a potential MACD crossover as a catalyst for a short‑term rally, and consider the bank’s dividend and valuation upside as primary drivers for medium‑ to long‑term positions.
Investors should monitor the support zone for any breach, watch for a potential MACD crossover as a catalyst for a short‑term rally, and consider the bank’s dividend and valuation upside as primary drivers for medium‑ to long‑term positions.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Oversold RSI indicating near‑term upside potential
- Proximity to strong technical support
- Bearish MACD suggesting caution
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF valuation showing significant upside
- Attractive dividend yield with sustainable payout
- Fundamental earnings metrics beating industry averages
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Stable cash flow generation and strong capital position
- Long‑term dividend income stream
- Undervaluation relative to intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth-25.00%
Profit Margin27.63%
P/E Ratio10.6
ROE13.49%
ROA1.01%
P/B Ratio126.6
Op. Cash FlowILA9.4B
Industry P/E16.4
Technical Analysis
TrendBullish
RSI35.2
SupportILA 3,393.00
ResistanceILA 4,107.00
MA 20ILA 3,837.80
MA 50ILA 3,752.68
MA 200ILA 3,264.76
MACDBearish
VolumeIncreasing
Fear & Greed Index73.13
Valuation
Fair ValueILA 9,451.83
Target PriceILA 3,858.00
Upside/Downside11.99%
GradeUndervalued
TypeValue
Dividend Yield4.15%
Risk Assessment
Beta0.44
Volatility39.27%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.